Clinical trial
Effect of Short-Term Intensive Insulin Sequential Exenatide Therapy on β-cell Function and Glycemic Remission Rate in Newly Diagnosed Type 2 Diabetic Patients
NCT01776788 is registered in ClinicalTrials.gov with The First Affiliated Hospital of Xiamen University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Short-Term Intensive Insulin Sequential Exenatide Therapy on β-cell Function and Glycemic Remission Rate in Newly Diagnosed Type 2 Diabetic Patients
- Lead sponsor
- The First Affiliated Hospital of Xiamen University
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- August 31, 2012
- Completion date
- February 28, 2015
- Enrollment
- 156 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.